Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Medshine Discovery divulges new GTPase KRAS G12C mutant inhibitors

Jan. 14, 2022

Icahn School of Medicine at Mount Sinai patents DYRK1A inhibitors

Jan. 14, 2022

Alchemedicine discovers CK1 and/or TGFBR1 inhibitors

Jan. 13, 2022

Roche synthesizes new Mat2A inhibitors

Jan. 13, 2022

AstraZeneca identifies new PARP-1 inhibitors

Jan. 13, 2022

Merck Sharp & Dohme presents new SCN10A blockers

Jan. 13, 2022

Autobahn Therapeutics patents thyroid hormone receptor agonists

Jan. 13, 2022

Wigen Biomedicine Technology presents new CDK inhibitors

Jan. 12, 2022

Betta Pharmaceuticals synthesizes new HIF-2alpha inhibitors

Jan. 12, 2022

Abbisko Therapeutics identifies new PD-1/PD-L1 interaction inhibitors

Jan. 12, 2022

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...